Chicago, IL, United States of America

Douglas K Bishop

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Douglas K Bishop

Introduction

Douglas K Bishop is an accomplished inventor based in Chicago, IL. He has made significant contributions to the field of molecular biology, particularly in the area of DNA repair mechanisms. With a total of two patents to his name, his work has important implications for cancer research and treatment.

Latest Patents

Bishop's latest patents focus on "Methods and compositions for modulating RAD51 and homologous recombination." This invention involves methods and compositions that utilize inhibitors and enhancers of RAD51, a protein crucial for homologous recombination. The invention outlines methods for stimulating homologous recombination, which has numerous significant research and clinical applications. Additionally, it describes methods for protecting cells using compounds that enhance RAD51 activity. These enhancers can help prevent or reduce damage to cells caused by DNA damaging agents. Furthermore, the invention includes methods for sensitizing cells to the effects of DNA damaging agents, which is particularly beneficial for cancer patients. In some embodiments, the RAD51 enhancer or inhibitor is a small molecule that directly influences RAD51 activity, such as its ability to promote filament formation.

Career Highlights

Douglas K Bishop is affiliated with the University of Chicago, where he conducts his research and development work. His innovative approaches to DNA repair mechanisms have positioned him as a notable figure in his field.

Collaborations

Bishop has collaborated with esteemed colleagues, including Philip Connell and Ralph R Weichselbaum, to advance research in molecular biology and cancer treatment.

Conclusion

Douglas K Bishop's contributions to the field of molecular biology through his patents and research are invaluable. His work on RAD51 and homologous recombination continues to pave the way for advancements in cancer therapies and cellular protection strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…